AEHL - RIOT MVIS MSRT and FOLD among premarket gainers
Galectin Therapeutics (GALT) +27% as its belapectin + Keytruda enhances tumor response in melanoma, head/neck cancer.Bit Digital (BTBT) +17%.UTStarcom Holdings (UTSI) +14%.Greenwich LifeSciences (GLSI) +15% after update on GP2 phase III clinical trial sesign.Moleculin Biotech (MBRX) +13% on Rare Pediatric status for WP1066 in ependymoma.Berry Corporation (BRY) +13%.Canaan (CAN) +9%.FLEX LNG (FLNG) +8%.The Lovesac Company (LOVE) +8% on Q4 results.Powerbridge Technologies (PBTS) +8%.Lion Group Holding (LGHL) +8%.MicroVision (MVIS) +8%.The9 Limited (NCTY) +7%.Riot Blockchain (RIOT) +6%.ImmunityBio (IBRX) +6%.MicroStrategy Incorporated (MSTR) +6%.Antelope Enterprise Holdings (AEHL) +6%.India Globalization Capital (IGC) +6%.Amicus Therapeutics (FOLD) +5%.Read (April 14): Coinbase’s widely awaited Nasdaq IPO set for Wednesday
For further details see:
RIOT, MVIS, MSRT and FOLD among premarket gainers